Evidence map›Paper›PMID 36814516›Full record

ArticleTherapeutic advances in infectious disease

Accelerating HIV epidemic control in Benue state, Nigeria, 2019-2021: the APIN program experience.

P Jwanle, O Ibiloye, M Obaje, K Ngwoke, T Usha, O Amoo, O Ogunsola, U Okezie, R Olaitan, E Ofuche and 7 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

P JwanleAPIN Public Health Initiatives, Abuja, Nigeria.
O IbiloyeAPIN Public Health Initiatives, Abuja, Nigeria.
M ObajeAPIN Public Health Initiatives, Plot 1551, Apo Resettlement, Zone E, Apo FCT, Abuja 900104, Nigeria.ORCID https://orcid.org/0000-0001-9326-9030
K NgwokeAPIN Public Health Initiatives, Abuja, Nigeria.
T UshaAPIN Public Health Initiatives, Abuja, Nigeria.
O AmooAPIN Public Health Initiatives, Abuja, Nigeria.
O OgunsolaAPIN Public Health Initiatives, Abuja, Nigeria.
U OkezieAPIN Public Health Initiatives, Abuja, Nigeria.
R OlaitanAPIN Public Health Initiatives, Abuja, Nigeria.
E OfucheAPIN Public Health Initiatives, Abuja, Nigeria.
I OnwuatueloAPIN Public Health Initiatives, Abuja, Nigeria.
J SamuelsAPIN Public Health Initiatives, Abuja, Nigeria.
J FagbamigbeCenters for Disease Control and Prevention, Abuja, Nigeria.
F NwagagboCenters for Disease Control and Prevention, Abuja, Nigeria.
O OgbanufeCenters for Disease Control and Prevention, Abuja, Nigeria.
M OkoyeCenters for Disease Control and Prevention, Abuja, Nigeria.
P OkonkwoAPIN Public Health Initiatives, Abuja, Nigeria.
AIDS Prevention Initiative in Nigeria · NGNigeria Centre for Disease Control · NG

Funding

2022 International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST)R13AI170098 · NIAID · DUKE UNIVERSITY · PI FERRARI, GUIDO · 2022 to 2022
$70k
NIAID NIH HHS R13 AI170098
6 · The paper itself

Abstract

Introduction: As at 2019, Nigeria was ranked the fourth highest HIV burden in the world. There is varied geographical HIV prevalence in Nigeria. The progress made is inequitable across geographical locations and sub-populations (18). Benue state has the second highest HIV prevalence in Nigeria. In 2018, about 35,623 people living with HIV (PLHIV) were yet to commence antiretroviral treatment (ART) in the state, accounting for an estimated ART coverage gap of 11% out of the combined gap of 320,921 in the country. To close this gap, the Benue ART surge (BAS) was implemented. The aim of this study was to describe the BAS strategic approaches and demonstrate progress in expanding ART access for PLHIV in Benue State, Nigeria. Methods: BAS was implemented in 252 health facilities from May 2019 to September 2021. Data were collected and reported using an Excel-based dashboard and electronic medical records. The trend of HIV case identification, ART initiation, viral load suppression rate, and rate of interruption in treatment during the BAS period was then described and analyzed. Results: Out of 893,462 clients reached, 6.7% ( Conclusion: Implementation of the BAS improved access to comprehensive HIV services in Benue State. The increase in HIV case identification and ART initiation significantly reduced the HIV treatment gap in the state. To fast track the attainment of UNAIDS 95-95-95 goals, lessons learnt from the BAS should be adapted and scaled up in the national HIV program in Nigeria.

Indexed as

antiretroviral therapyARTART surgeHIV

Identifiers

PMID36814516
PMCPMC9940220
OpenAlexW4321333645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.